Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis.

Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis. JACC Cardiovasc Interv. 2016 05 23; 9(10):1036-46.

View in: PubMed

subject areas

Adenosine
Adenosine
Antithrombins
Antithrombins
Bayes Theorem
Bayes Theorem
Blood Platelets
Blood Platelets
Clinical Trials as Topic
Clinical Trials as Topic
Coronary Thrombosis
Coronary Thrombosis
Drug-Eluting Stents
Drug-Eluting Stents
Evidence-Based Medicine
Evidence-Based Medicine
Hirudins
Hirudins
Humans
Humans
Markov Chains
Markov Chains
Monte Carlo Method
Monte Carlo Method
Network Meta-Analysis
Network Meta-Analysis
Odds Ratio
Odds Ratio
Peptide Fragments
Peptide Fragments
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Prasugrel Hydrochloride
Prasugrel Hydrochloride
Purinergic P2Y Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Receptors, Purinergic P2Y12
Receptors, Purinergic P2Y12
Recombinant Proteins
Recombinant Proteins
Risk Factors
Risk Factors
ST Elevation Myocardial Infarction
ST Elevation Myocardial Infarction
Ticlopidine
Ticlopidine
Treatment Outcome
Treatment Outcome

authors with profiles

Usman Baber